Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Legend Biotech
ISIN US52490G1022
|WKN A2P5AH
Market cap (in EUR)
3,030 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States
Données financières
Indicateurs clés
| Capitalisation boursière, EUR | 3,030 m |
| BPA, EUR | -1.43 |
| Ratio cours/valeur comptable | 3.5 |
| PER | - |
| Rendement en dividendes | 0.00% |
Income statement (2025)
| Chiffre d'affaires, EUR | 914 m |
| Résultat net, EUR | -264 m |
| Marge bénéficiaire | -28.85% |
What ETF is Legend Biotech in?
There are 8 ETFs which contain Legend Biotech. All of these ETFs are listed in the table below. The ETF with the largest weighting of Legend Biotech is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
| ETF | Poids | Objectif d'investissement | Taille fonds en M € |
|---|---|---|---|
| iShares MSCI AC Far East ex-Japan UCITS ETF | 0.01% | Equity Asia Pacific | 1,168 |
| iShares MSCI ACWI UCITS ETF USD (Acc) | 0.00% | Equity World | 22,692 |
| UBS Core MSCI EM UCITS ETF USD dis | 0.01% | Equity Emerging Markets | 2,116 |
| iShares MSCI EM UCITS ETF (Dist) | 0.01% | Equity Emerging Markets | 7,600 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.11% | Equity United States Health Care Biotech | 47 |
| Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist | 0.02% | Equity Emerging Markets | 897 |
| iShares MSCI EM IMI Screened UCITS ETF USD (Dist) | 0.01% | Equity Emerging Markets Social/Environmental | 1,270 |
| iShares MSCI EM ESG Enhanced CTB UCITS ETF USD (Dist) | 0.00% | Equity Emerging Markets Social/Environmental | 994 |
Articles les plus récents
Articles les plus consultés
— Les données utilisées sont mises à disposition par Trackinsight, etfinfo, Xignite Inc., gettex, FactSet et justETF GmbH. Les cotations sont des cotations en temps réel (gettex), des cotations boursières retardées de 15 minutes ou des VNI (quotidiennes publiées par le fournisseur du fonds). Par défaut, les rendements des ETF incluent les paiements de dividendes (le cas échéant). Aucune garantie n'est donnée quant à l'exhaustivité, la précision et l'exactitude des informations affichées.